Last reviewed · How we verify

NCT06676683

The Use of Statin in Diabetic Patients Not Known to Have Atherosclerotic Cardiovascular Disease

Not yet recruiting Last updated 6 November 2024
What this trial tests

trial testing Usage of Statin in diabetic patients in Diabete Type 2 in 300 participants. Not yet recruiting.

Timeline
1 December 2024
Primary endpoint
1 November 2025
1 December 2025

Quick facts

Lead sponsorSohag University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment300
Start date1 December 2024
Primary completion1 November 2025
Estimated completion1 December 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

18 and older, any sex, with Diabete Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the use of Statin in diabetic patients and its correlation to the guidelines recommendation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabete Type 2

Currently open trials in the same condition.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06676683.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing